135 related articles for article (PubMed ID: 1374630)
1. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor (rhG-CSF) and erythropoietin (rhEpo) in severe aplastic anaemia.
Bessho M; Toyoda A; Itoh Y; Sakata T; Kawai N; Jinnai I; Saito M; Hirashima K
Br J Haematol; 1992 Mar; 80(3):409-11. PubMed ID: 1374630
[No Abstract] [Full Text] [Related]
2. Combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in aplastic anemia.
Imamura M; Kobayashi M; Kobayashi S; Yoshida K; Mikuni C; Ishikawa Y; Matsumoto S; Sakamaki S; Niitsu Y; Hinoda Y
Am J Hematol; 1995 Jan; 48(1):29-33. PubMed ID: 7530405
[TBL] [Abstract][Full Text] [Related]
3. Haematological improvement by long-term administration of recombinant human granulocyte-colony stimulating factor and recombinant human erythropoietin in a patient with severe aplastic anaemia.
Nawata J; Toyoda Y; Nisihira H; Honda K; Kigasawa H; Nagao T
Eur J Pediatr; 1994 May; 153(5):325-7. PubMed ID: 7518392
[TBL] [Abstract][Full Text] [Related]
4. Hematologic response in patients with aplastic anemia after long-term administration of recombinant human granulocyte colony-stimulating factor and erythropoietin.
Yonekura S; Kawada H; Watanabe S; Masumoto A; Ogawa Y; Fukuda R; Nishihira H; Matsuyama S; Katoh S; Mouri H; Motomura S; Shionoya S; Hotta T
Clin Ther; 1997; 19(6):1394-407. PubMed ID: 9444448
[TBL] [Abstract][Full Text] [Related]
5. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in patients with aplastic anemia and refractory anemia.
Bessho M; Jinnai I; Hirashima K; Saito M; Murohashi I; Ino H; Tsuji M; Fukuda M; Maruyama M; Kusumoto S
Stem Cells; 1994 Nov; 12(6):604-15. PubMed ID: 7533579
[TBL] [Abstract][Full Text] [Related]
6. Early trilineage recovery by granulocyte colony-stimulating factor in a patient with aplastic anemia.
Hashimoto K; Kanakura Y; Yagura H; Mitsui H; Ogawa M; Horikawa Y; Nishiura T; Kanayama Y; Matsuzawa Y
Acta Haematol; 1995; 93(2-4):110-2. PubMed ID: 7543718
[No Abstract] [Full Text] [Related]
7. Trilineage response in severe aplastic anemia following long-term therapy with recombinant human granulocyte colony-stimulating factor.
Ashihara E; Shimazaki C; Hirata T; Okawa K; Oku N; Goto H; Inaba T; Fujita N; Nakagawa M
Acta Haematol; 1993; 90(3):159-61. PubMed ID: 7507289
[TBL] [Abstract][Full Text] [Related]
8. [Aplastic anemia successfully treated with erythropoietin and rhG-CSF].
Higashino K; Kito K; Hodohara K; Fujiyama Y; Banba T; Hosoda S
Rinsho Ketsueki; 1992 Sep; 33(9):1237-41. PubMed ID: 1279235
[TBL] [Abstract][Full Text] [Related]
9. Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia.
Kurzrock R; Talpaz M; Gutterman JU
Am J Med; 1992 Jul; 93(1):41-8. PubMed ID: 1626572
[TBL] [Abstract][Full Text] [Related]
10. Sustained trilineage response in a patient with ALG-resistant severe aplastic anaemia after treatment with G-CSF, erythropoietin and cyclosporin A: association of recovery with marked elevation of serum alkaline phosphatase.
Weide R; Lyttelton M; Samson D; Görg C; Köppler H; Pflüger KH; Havemann K
Br J Haematol; 1993 Nov; 85(3):608-10. PubMed ID: 7510993
[TBL] [Abstract][Full Text] [Related]
11. [Clinical effect of recombinant human granulocyte colony-stimulating factor on aplastic anemia].
Asano S; Hirashima K; Yoshida Y; Takaku F; Miyazaki T; Omine M; Furusawa S; Abe T; Mori M; Arimori S
Rinsho Ketsueki; 1990 Sep; 31(9):1456-62. PubMed ID: 1701008
[TBL] [Abstract][Full Text] [Related]
12. Multilineage response in aplastic anemia patients following long-term administration of filgrastim (recombinant human granulocyte colony stimulating factor).
Sonoda Y; Ohno Y; Fujii H; Takahashi T; Nakayama S; Haruyama H; Nasu K; Shimazaki C; Hara H; Kanamaru A
Stem Cells; 1993 Nov; 11(6):543-54. PubMed ID: 7509223
[TBL] [Abstract][Full Text] [Related]
13. Treatment of the anemia of aplastic anemia patients with recombinant human erythropoietin in combination with granulocyte colony-stimulating factor: a multicenter randomized controlled study. Multicenter Study Group.
Bessho M; Hirashima K; Asano S; Ikeda Y; Ogawa N; Tomonaga M; Toyama K; Nakahata T; Nomura T; Mizoguchi H; Yoshida Y; Niitsu Y; Kohgo Y
Eur J Haematol; 1997 Apr; 58(4):265-72. PubMed ID: 9186538
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of aplastic anemia with KRN8601 (rhG-CSF)].
Kojima S; Matsuyama T; Miyazaki T; Sakurada K; Shike S; Okino E; Akabane T; Nakahata T; Okuni M; Mugishima H
Rinsho Ketsueki; 1990 Jul; 31(7):929-36. PubMed ID: 1699006
[TBL] [Abstract][Full Text] [Related]
15. Failure of combination therapy with recombinant granulocyte colony-stimulating factor and erythropoietin in myelodysplastic syndromes.
Imamura M; Kobayashi M; Kobayashi S; Yoshida K; Mikuni C; Ishikawa Y; Matsumoto S; Sakamaki S; Niitsu Y; Hinoda Y
Ann Hematol; 1994 Apr; 68(4):163-6. PubMed ID: 7516190
[TBL] [Abstract][Full Text] [Related]
16. [Two patients with aplastic anemia successfully treated with G-CSF and erythropoietin].
Hanamura A; Ichikawa A; Utsumi M; Hotta T
Rinsho Ketsueki; 1995 Dec; 36(12):1347-52. PubMed ID: 8587170
[TBL] [Abstract][Full Text] [Related]
17. Aplastic anaemia with a trilineage response to erythropoietin therapy.
Bernell P
J Intern Med; 1996 Jan; 239(1):79-81. PubMed ID: 8551205
[TBL] [Abstract][Full Text] [Related]
18. Unmaintained trilineage response to recombinant human erythropoietin in a patient with myelodysplasia.
Jones D; Zeigler ZR; Rosenfeld CS; Shadduck RK
Br J Haematol; 1992 Mar; 80(3):406-7. PubMed ID: 1581221
[No Abstract] [Full Text] [Related]
19. [G-CSF (Neupogen Roche) in the treatment of patients with chronic aplastic anemia with severe neutropenia].
Novotný J; Zvarová M; Prazáková L; Jandlová M; Konvicková L
Vnitr Lek; 1995 Oct; 41(10):692-5. PubMed ID: 8578701
[TBL] [Abstract][Full Text] [Related]
20. In vitro study of erythropoiesis in patients with aplastic anemia and myelodysplastic syndromes: a possible tool for prospective determination of the clinical effectiveness of growth factors.
Aoki A; Shibata A
Hematol Pathol; 1992; 6(3):143-53. PubMed ID: 1429342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
